SCHEMBL92576

SCHEMBL92576

CC1(CN)CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5118439 1.00 USP2 (0.36) —
SCHEMBL19069681 1.00 USP2 (0.36) —
SCHEMBL18610573 1.00 USP2 (0.36) —
SCHEMBL13849408 1.00 USP2 (0.36) —
SCHEMBL18879736 1.00 USP2 (0.36) —
SCHEMBL12361078 1.00 USP2 (0.36) —
SCHEMBL19242261 1.00 USP2 (0.36) —
SCHEMBL12361074 1.00 USP2 (0.36) —
Hydrochloric Acid SCHEMBL25345453 0.97 USP2 (0.34) —
SCHEMBL3249011 0.97 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7193077-B2 Exocyclic amine triaryl methyl protecting groups in two-step polynucleotide synthesis AGILENT TECHNOLOGIES, INC. (US) 2007-03-20 — — US claimed
US-5602244-A DINUCLEOSIDE PRECURSORS IN OLIGONUCLEOTIDE SYNTHESIS; USEFUL AS ANTISENSE INHIBITORS OF TRANSLATION COMPETITIVE TECHNOLOGIES, INC. (US) 1997-02-11 — — US claimed
EP-0144386-B1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES BECKMAN INSTRUMENTS, INC. (US) 1989-09-06 — — EP claimed
EP-0144386-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES. BECKMAN INSTRUMENTS INC (US) 1985-06-19 — — EP claimed
WO-1984004749-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES BECKMAN INSTRUMENTS INC (US) 1984-12-06 — — WO claimed
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP disclosed
US-12435051-B2 Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof VIVOZON, INC. (KR) 2025-10-07 — — US disclosed
CN-112533902-B Composition comprising a nitroxide inhibitor, a quinone methide blocker and an amine stabilizer to inhibit polymerization of monomers 埃科莱布美国股份有限公司 2025-03-14 — — CN disclosed
CN-116234552-B Dual modulators of mGluR5 and 5-HT2A receptors and uses thereof (株)倍宝尊 2025-02-25 — — CN disclosed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO disclosed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP disclosed
US-20240360092-A1 DUAL MODULATOR OF MGLUR5 AND 5-HT2A RECEPTOR, AND USE THEREOF VIVOZON INC. (KR) 2024-10-31 — — US disclosed
EP-0225807-A2 Solution phase nucleic acid sandwich assay and polynucleotide probes useful therein CHIRON CORPORATION (US) 1987-06-16 — — EP disclosed
US-4668777-A POLYNUCLEOTIDE INTERMEDIATES UNIVERSITY PATENTS, INC. (US) 1987-05-26 — — US disclosed
EP-0196101-A2 Purification of synthetic oligomers CHIRON CORPORATION (US) 1986-10-01 — — EP disclosed
EP-0144386-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES. BECKMAN INSTRUMENTS INC (US) 1985-06-19 — — EP disclosed
WO-1984004749-A1 NOVEL PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITE INTERMEDIATES BECKMAN INSTRUMENTS INC (US) 1984-12-06 — — WO disclosed
US-4415732-A STORAGE-STABLE NUCLEOSIDES; POLYNUCLEOTIDE SYNTHESIS UNIVERSITY PATENTS, INC. (US) 1983-11-15 — — US disclosed
EP-0061746-A1 Phosphoramidite compounds and their use in producing oligonucleotides UNIVERSITY PATENTS, INC. (US) 1982-10-06 — — EP disclosed
US-4024175-A Cyclic amino acids WARNER-LAMBERT COMPANY (US) 1977-05-17 — — US disclosed
Send feedback